A new era in the management of psoriasis? The biologics: facts and controversies

Carlos Ferrándiz, Jose Manuel Carrascosa, Aram Boada

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)

Abstract

During the last 30 years, the tremendous progress in our knowledge of the pathogenesis of psoriasis has led to the development of new agents, the so-called biologics, that have revolutionized the management of severe psoriasis. Dermatologists and patients see this emerging therapy as a new perspective in the state of the art in managing moderate to severe psoriasis. After a few years of use in daily practice, we may begin to analyze the power of the currently available biologic agents in the management of severe psoriasis from the perspective of facts. © 2010 Elsevier Inc. All rights reserved.
Original languageEnglish
Pages (from-to)81-87
JournalClinics in Dermatology
Volume28
Issue number1
DOIs
Publication statusPublished - 1 Jan 2010

Fingerprint Dive into the research topics of 'A new era in the management of psoriasis? The biologics: facts and controversies'. Together they form a unique fingerprint.

  • Cite this